Physician profile
Robert M Lampert
NPI 1972547206
$7,919.66
in general payments reported to CMS, 2019-2025
43 companies · $562 in 2025
The $562 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,962 · 2020: $1,189 · 2021: $1,111 · 2022: $1,388 · 2023: $949 · 2024: $760 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,216 · Education: $55.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,215.66 |
| Education | $55.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,430.90 | 2019-2025 | Breztri, Airsupra, Symbicort |
| Glaxosmithkline, LLC. | $1,339.75 | 2019-2025 | Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $891.07 | 2019-2025 | Ofev, Jascayd |
| Actelion Pharmaceuticals US, INC. | $757.75 | 2019-2025 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $524.99 | 2019-2025 | Dupixent |
| Genzyme Corporation | $522.97 | 2019-2025 | |
| Philips North America LLC | $230.98 | 2019-2020 | |
| Amgen INC. | $203.17 | 2020-2023 | Tezspire |
| Merck Sharp & Dohme LLC | $190.08 | 2022-2025 | Winrevair |
| Intuitive Surgical, INC. | $187.86 | 2019 | |
| Boston Scientific Corporation | $150.19 | 2023 | Icefx Cryoablation System |
| Genentech USA, INC. | $141.32 | 2019-2021 | |
| Insmed, INC. | $138.53 | 2019-2021 | |
| Circassia INC. | $93.78 | 2019-2020 | |
| Pfizer INC. | $90.01 | 2019-2020 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lampert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.